| |
Detected Viral Genes (Tallies)
|
Aligned%
|
---|
Transcripts
|
+
|
+
|
-
|
-
|
T%
§
| |
---|
Proteins
|
-
|
+
|
+
|
-
| |
P%
|
KSHV
| | | | | | | |
BCBL-1
|
Latent
|
34
|
53
|
3
|
7
|
68%
|
95%
|
|
* Lytic
|
31
|
56
|
3
|
7
|
*
|
95%
|
BC-1
|
Latent
|
28
|
10
|
10
|
49
|
31%
|
50%
|
|
Lytic
|
45
|
37
|
5
|
10
|
51%
|
88%
|
EBV
| | | | | | | |
BC-1
|
Latent
|
21
|
2
|
12
|
58
|
11%
|
14%
|
|
Lytic
|
18
|
13
|
28
|
34
|
46%
|
32%
|
- +/- Column: # viral genes detected at only the transcript level
- +/+ Column: # viral genes detected at both transcript and protein levels (indicated in bold)
- -/+ Column: # viral genes detected at only the protein level
- -/- Column: # viral genes not detected at either level
- Total Transcripts Possible: KSHV = 97; EBV = 93 (row totals)
- Detected Transcripts (+) ≥1.25-fold over reference sample
- Undetected Transcripts (-) <1.25-fold over reference sample
- Total Proteins Possible: KSHV = 86; EBV = 86
- Detected Proteins (+): spectra are observed with the protein
- Undetected Proteins (-): spectra are not observed with the protein
- Aligned%= 100% × +/+ column ÷ total detected transcripts (T%) or total detected proteins (P%)
- §Transcript-to-protein alignments (%) were adjusted to remove non-coding RNAs from the denominator.
- * BCBL-1 latent transcripts were aligned to lytic proteins (no transcript analysis was performed with lytic BCBL-1).